Docsity
Docsity

Prepare for your exams
Prepare for your exams

Study with the several resources on Docsity


Earn points to download
Earn points to download

Earn points by helping other students or get them with a premium plan


Guidelines and tips
Guidelines and tips

FDA v Brown and Williamson - Law - Case Study, Study Guides, Projects, Research of Law

Fda v Brown and Williamson, Cosmetic Act, Authority to Regulate, Asserted Jurisdiction, Smokeless Tobacco, Promotion, Advertisers, Summary Judgement, Therapeutic Benefit, Overstepped Its Authority. Case study for law students.

Typology: Study Guides, Projects, Research

2011/2012

Uploaded on 12/11/2012

amulya
amulya 🇮🇳

5

(3)

123 documents

1 / 2

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
FDA v. Brown & Williamson
Tobacco Corp.
529 U.S. 120 (2000)
Docket Number: 98-1152
Abstract
Argued:
December 1, 1999
Decided:
March 21, 2000
Subjects:
Economic Activity: Consumer Protection
Facts of the Case
he Food, Drug, and Cosmetic Act (FDCA) grants the Food and Drug
Administration (FDA) the authority to regulate, among other items, "drugs"
and "devices." In 1996, the FDA asserted jurisdiction to regulate tobacco
products, concluding that, under the FDCA, nicotine is a "drug" and
cigarettes and smokeless tobacco are "devices" that deliver nicotine to the
body. Accordingly, the FDA promulgated regulations governing tobacco
products' promotion, labeling, and accessibility to children and adolescents.
Brown & Williamson Tobacco Corporation, and a group of tobacco
manufacturers, retailers, and advertisers, filed suit challenging the FDA's
regulations. Brown moved for summary judgement on the ground that the
FDA lacked the jurisdiction to regulate tobacco products as customarily
marketed, or without manufacturer claims of therapeutic benefit. The
District Court ruled that the FDA had jurisdiction over tobacco as a device,
but that the agency had overstepped its authority in attempting to restrict
tobacco advertising. In reversing, the Court of Appeals held that Congress
had not granted the FDA jurisdicti
on to regulate tobacco products. The court
found that the FDA's definition of tobacco as a device was flawed because
the agency could not prove that the impact of tobacco products on the body
was "intended" under the act.
Question Presented
Does the Food and Drug Administration have the authority to regulate
tobacco products as "drugs" and "devices" under the Food, Drug, and
Cosmetic Act?
pf2

Partial preview of the text

Download FDA v Brown and Williamson - Law - Case Study and more Study Guides, Projects, Research Law in PDF only on Docsity!

FDA v. Brown & Williamson

Tobacco Corp.

529 U.S. 120 (2000)

Docket Number: 98-

Abstract

Argued: December 1, 1999 Decided: March 21, 2000

Subjects: Economic Activity: Consumer Protection

Facts of the Case

he Food, Drug, and Cosmetic Act (FDCA) grants the Food and Drug Administration (FDA) the authority to regulate, among other items, "drugs" and "devices." In 1996, the FDA asserted jurisdiction to regulate tobacco products, concluding that, under the FDCA, nicotine is a "drug" and cigarettes and smokeless tobacco are "devices" that deliver nicotine to the body. Accordingly, the FDA promulgated regulations governing tobacco products' promotion, labeling, and accessibility to children and adolescents. Brown & Williamson Tobacco Corporation, and a group of tobacco manufacturers, retailers, and advertisers, filed suit challenging the FDA's regulations. Brown moved for summary judgement on the ground that the FDA lacked the jurisdiction to regulate tobacco products as customarily marketed, or without manufacturer claims of therapeutic benefit. The District Court ruled that the FDA had jurisdiction over tobacco as a device, but that the agency had overstepped its authority in attempting to restrict tobacco advertising. In reversing, the Court of Appeals held that Congress had not granted the FDA jurisdiction to regulate tobacco products. The court found that the FDA's definition of tobacco as a device was flawed because the agency could not prove that the impact of tobacco products on the body was "intended" under the act.

Question Presented

Does the Food and Drug Administration have the authority to regulate tobacco products as "drugs" and "devices" under the Food, Drug, and Cosmetic Act?

Conclusion

No. In a 5-4 opinion delivered by Justice Sandra Day O'Connor, the Court held that "Congress has not given the FDA the authority to regulate tobacco products as customarily marketed." The ruling was based on the FDCA as a whole and in conjunction with Congress' subsequent tobacco-specific legislation. "By no means do we question the seriousness of the problem that the FDA has sought to address," Justice O'Connor wrote for the majority. Nonetheless, Justice O' Connor wrote, "Congress, for better or for worse, has created a distinct regulatory scheme for tobacco products, squarely rejected proposals to give the FDA jurisdiction over tobacco, and repeatedly acted to preclude any agency from exercising significant policymaking authority in the area."